1. Catalog
  2. The Metabolic Paradox: Understanding the Interplay ...
The Metabolic Paradox: Understanding the Interplay Between Obesity and MASLD/MASH Series
Availability
On-Demand
4 Courses
Cost
$0.00
Credit Offered
No Credit Offered
  • Program Information
  • Target Audience
  • Learning Objectives
  • Faculty
  • Commercial Support
  • Recommended
This 4-part course is designed to support the endocrine care team in enhancing foundational knowledge and skills involved in managing patients with MASLD/MASH. With topics that range from screening tools, diagnosis, and the relationship between obesity and liver disease, this course focuses on case-based strategies to engage learners in the practical application. This series is designed to support members of the endocrine team in the identification, treatment, and management of MASLD/MASH and the connection between liver disease management and weight loss interventions. This course includes the latest treatment guidelines and algorithms, emerging pharmacotherapies, and evidence-based approaches for shared decision making and using a team-based approach.

This online course includes 4 modules, releasing between September and November 2025.
This educational series has been designed for the full endocrine care team, including endocrinologists, primary care physicians, and allied health professionals like nurses and physician assistants.

Upon completion of this program, learners will be able to:

  • Describe the current guidelines and recommendations for MASLD and MASH screening and diagnosis while addressing clinical inertia. 
  • Examine collaborative care models that effectively leverage the endocrine care team and specialists to streamline the MASLD and MASH screening processes and enhance comprehensive patient care across multiple specialties. 
  • Identify the key factors in early screening contributing to the development and progression of MASLD and MASH in patients with obesity. 
  • Develop a strategy for incorporating non-invasive tests and digital biomarkers into clinical practice for MASLD and MASH management.
  • Apply a person-centered, evidence-based treatment plan for patients with MASLD and MASH, incorporating individualized lifestyle modifications and pharmacological therapies as appropriate.  
  • Develop long-term patient management strategies to monitor progression and ensure sustained patient engagement. 

Kim Pfotenhauer, DO, FACOFP, DABOM

Assistant Dean for Clerkship Education

Michigan State University

College of Osteopathic Medicine

Office of Medical Education

Sarah R. Barenbaum, M.D.

Assistant Professor of Clinical Medicine

Weill Cornell Medicine

Comprehensive Weight Control Center

Division of Endocrinology, Diabetes & Metabolism

Sangeeta Kashyap MD
Assistant Chief of Clinical Affairs

Professor of Clinical Medicine
New York-Presbyterian/Weill Cornell Medical Center
Weill Cornell Medicine
Endocrinology, Diabetes and Metabolism

Aman Rajpal, MD, Dipl. of ABOM

Diplomate, American Board of Clinical Lipidology

Assistant Clinical Professor, UCSF
Chief of Endocrinology, Department of Medicine
Alameda Health System 
This program is funded by Boehringer Ingelheim.
Powered By